Patents by Inventor Reiko Yasuda
Reiko Yasuda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9844226Abstract: A substance is described which is capable of imparting a kokumi, which shows a more excellent kokumi-imparting effect, in particular, the initial taste-imparting type of kokumi-imparting effect, which is excellent in the stability and which can easily be produced at a low cost. Additionally, a kokumi-imparting composition which includes a substance as well as a kokumi-imparting agent including the substance and other substances possessing the CaSR agonist activities in combination. More particularly, the present invention herein provides a kokumi-imparting composition consisting of ?-Glu-Abu (L-?-glutamyl-L-2-amino-butyric acid) and a complex kokumi-imparting agent which includes the foregoing substance and another substance having a CaSR agonist activity, in combination.Type: GrantFiled: September 30, 2011Date of Patent: December 19, 2017Assignee: AJINOMOTO CO., INC.Inventors: Fumie Futaki, Reiko Yasuda, Seiichi Sato, Takashi Miyaki, Naohiro Miyamura, Yuzuru Eto
-
Patent number: 9174932Abstract: By searching various kinds of compounds having CaSR agonistic activity, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise the compound. More specifically, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise a glutamic acid derivative having CaSR agonistic activity or pharmaceutically acceptable salts thereof.Type: GrantFiled: March 28, 2014Date of Patent: November 3, 2015Assignee: AJINOMOTO CO., INC.Inventors: Masayuki Sugiki, Toru Okamatsu, Sayaka Asari, Yayoi Kawato, Toshihiro Hatanaka, Tetsuo Yano, Yukie Seki, Naohiro Miyamura, Hiroaki Nagasaki, Yuzuru Eto, Reiko Yasuda
-
Patent number: 9150505Abstract: An object is to provide a CaSR agonist agent that has excellent CaSR agonist effects, and particularly, a pharmaceutical product that can prevent or remedy diabetes or obesity by the effect of CaSR activation. The aforementioned object is achieved by a composition that contains a compound represented by the following General Formula (I) or a salt thereof (refer to the Description for the definitions of the symbols used in the formula).Type: GrantFiled: August 31, 2012Date of Patent: October 6, 2015Assignee: AJINOMOTO CO., INC.Inventors: Reiko Yasuda, Yuzuru Eto, Yoshiro Kitahara
-
Patent number: 9037663Abstract: A server (11) includes a history registration unit (73) that acquires information of a recommendation email for recommending a specified recommended object from a first user to a second user, generates recommendation data in which the first user, the second user and a web page of the recommended object are associated based on the information, and registers the recommendation data into a history database (63), an operation information acquisition unit (76) that acquires operation information indicating operation performed by the second user on the web page of the recommended object in response to the recommendation email, and a history update unit (77) that specifies an action of the second user taken on the recommended object based on the operation information and adds action information indicating the specified action to the corresponding recommendation data.Type: GrantFiled: May 31, 2011Date of Patent: May 19, 2015Assignee: Rakuten, Inc.Inventors: Masahiro Watanabe, Manabu Oshiro, Noriko Harada, Hidekazu Hamada, Reiko Yasuda, Teppei Hida, Yuko Furusho, Koichi Yanagimoto, Ai Shimogori
-
Patent number: 8935345Abstract: The server 11 includes a recommendation email generation unit 72 that generates a recommendation email for recommending a recommended object to a plurality of second users based on recommendation information indicating that a first user recommends a specified recommended object to the plurality of second users, a recommendation email sending unit 73 that sends the recommendation email to the plurality of second users, a purchase email generation unit 74 that, when one of the plurality of second users applies for the recommended object indicated in the recommendation email and becomes an applicant for the recommended object, generates an application email containing application information indicating an application for the recommended object, and a purchase email sending unit 75 that sends the application email to the second users other than the applicant.Type: GrantFiled: May 31, 2011Date of Patent: January 13, 2015Assignee: Rakuten, Inc.Inventors: Masahiro Watanabe, Manabu Oshiro, Noriko Harada, Hidekazu Hamada, Reiko Yasuda, Teppei Hida, Yuko Furusho, Koichi Yanagimoto, Ai Shimogori
-
Patent number: 8877739Abstract: A medicament having an excellent CaSR agonist action which enables the prevention or treatment of diabetes or obesity is provided by a composition comprising the compound represented by general formula (I) as defined, or a salt thereof.Type: GrantFiled: September 28, 2012Date of Patent: November 4, 2014Assignee: Ajinomoto Co., Inc.Inventors: Reiko Yasuda, Yuzuru Eto
-
Publication number: 20140303122Abstract: By searching various kinds of compounds having CaSR agonistic activity, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise the compound. More specifically, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise a glutamic acid derivative having CaSR agonistic activity or pharmaceutically acceptable salts thereof.Type: ApplicationFiled: March 28, 2014Publication date: October 9, 2014Applicant: AJINOMOTO CO., INC.Inventors: Masayuki SUGIKI, Toru Okamatsu, Sayaka Asari, Yayoi Kawato, Toshihiro Hatanaka, Tetsuo Yano, Yukie Seki, Naohiro Miyamura, Hiroaki Nagasaki, Yuzuru Eto, Reiko Yasuda
-
Patent number: 8796485Abstract: By searching various kinds of compounds having CaSR agonistic activity, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise the compound. More specifically, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise a glutamic acid derivative having CaSR agonistic activity or pharmaceutically acceptable salts thereof.Type: GrantFiled: April 4, 2011Date of Patent: August 5, 2014Assignee: Ajinomoto Co., Inc.Inventors: Masayuki Sugiki, Toru Okamatsu, Sayaka Asari, Yayoi Kawato, Toshihiro Hatanaka, Tetsuo Yano, Yukie Seki, Naohiro Miyamura, Hiroaki Nagasaki, Yuzuru Eto, Reiko Yasuda
-
Patent number: 8568814Abstract: The present invention provides a variety of compounds having a CaSR agonist activity which possesses a superior kokumi-imparting function, and more particularly provides a kokumi-imparting composition, which contains the foregoing compound, and/or another substance having a CaSR agonist activity, in combination. The present invention also provides a kokumi-imparting composition which includes a lanthionine derivative and/or another substance having a CaSR agonist activity.Type: GrantFiled: June 26, 2012Date of Patent: October 29, 2013Assignee: Ajinomoto Co., Inc.Inventors: Seiichi Sato, Fumie Futaki, Reiko Yasuda, Sachise Eto, Yumiko Suzuki, Takaho Tajima, Yuzuru Eto, Yuki Tahara
-
Patent number: 8541379Abstract: A substance capable of imparting a kokumi having CaSR agonist activity is described. This substance is able to impart kokumi in a superior manner, in particular, at the initial taste, and is also highly stable and can easily be produced at a low cost. The present invention thus provides a kokumi-imparting composition which includes such a substance as well as a complex kokumi-imparting composition which includes the substance and other substances possessing the CaSR agonist activities in combination. More particularly, the present invention herein provides a kokumi-imparting composition including ?-Glu-Nva (L-?-glutamyl-L-norvaline), and a complex kokumi-imparting composition including the foregoing substance and another substance having a CaSR agonist activity, in combination.Type: GrantFiled: June 21, 2012Date of Patent: September 24, 2013Assignee: Ajinomoto Co., Inc.Inventors: Takashi Miyaki, Naohiro Miyamura, Megumi Kaneko, Yusuke Amino, Reiko Yasuda, Yuzuru Eto, Takaho Tajima
-
Publication number: 20130132491Abstract: A server (11) includes a history registration unit (73) that acquires information of a recommendation email for recommending a specified recommended object from a first user to a second user, generates recommendation data in which the first user, the second user and a web page of the recommended object are associated based on the information, and registers the recommendation data into a history database (63), an operation information acquisition unit (76) that acquires operation information indicating operation performed by the second user on the web page of the recommended object in response to the recommendation email, and a history update unit (77) that specifies an action of the second user taken on the recommended object based on the operation information and adds action information indicating the specified action to the corresponding recommendation data.Type: ApplicationFiled: May 31, 2011Publication date: May 23, 2013Applicant: RAKUTEN, INC.Inventors: Masahiro Watanabe, Manabu Oshiro, Noriko Harada, Hidekazu Hamada, Reiko Yasuda, Teppei Hida, Yuko Furusho, Koichi Yanagimoto, Ai Shimogori
-
Publication number: 20130080549Abstract: The server 11 includes a recommendation email generation unit 72 that generates a recommendation email for recommending a recommended object to a plurality of second users based on recommendation information indicating that a first user recommends a specified recommended object to the plurality of second users, a recommendation email sending unit 73 that sends the recommendation email to the plurality of second users, a purchase email generation unit 74 that, when one of the plurality of second users applies for the recommended object indicated in the recommendation email and becomes an applicant for the recommended object, generates an application email containing application information indicating an application for the recommended object, and a purchase email sending unit 75 that sends the application email to the second users other than the applicant.Type: ApplicationFiled: May 31, 2011Publication date: March 28, 2013Applicant: RAKUTEN, INC.Inventors: Masahiro Watanabe, Manabu Oshiro, Noriko Harada, Hidekazu Hamada, Reiko Yasuda, Teppei Hida, Yuko Furusho, Koichi Yanagimoto, Ai Shimogori
-
Publication number: 20130072491Abstract: An object is to provide a CaSR agonist agent that has excellent CaSR agonist effects, and particularly, a pharmaceutical product that can prevent or remedy diabetes or obesity by the effect of CaSR activation. The aforementioned object is achieved by a composition that contains a compound represented by the following General Formula (I) or a salt thereof (refer to the Description for the definitions of the symbols used in the formula).Type: ApplicationFiled: August 31, 2012Publication date: March 21, 2013Applicant: Ajinomoto Co., Inc.Inventors: Reiko YASUDA, Yuzuru Eto, Yoshiro Kitahara
-
Publication number: 20120282386Abstract: The present invention provides a variety of compounds having a CaSR agonist activity which possesses a superior kokumi-imparting function, and more particularly provides a kokumi-imparting composition, which contains the foregoing compound, and/or another substance having a CaSR agonist activity, in combination. The present invention also provides a kokumi-imparting composition which includes a lanthionine derivative and/or another substance having a CaSR agonist activity.Type: ApplicationFiled: June 26, 2012Publication date: November 8, 2012Inventors: Seiichi Sato, Fumie Futaki, Reiko Yasuda, Sachise Eto, Yumiko Suzuki, Takaho Tajima, Yuzuru Eto, Yuki Tahara
-
Publication number: 20120277168Abstract: A substance capable of imparting a kokumi having CaSR agonist activity is described. This substance is able to impart kokumi in a superior manner, in particular, at the initial taste, and is also highly stable and can easily be produced at a low cost. The present invention thus provides a kokumi-imparting composition which includes such a substance as well as a complex kokumi-imparting composition which includes the substance and other substances possessing the CaSR agonist activities in combination. More particularly, the present invention herein provides a kokumi-imparting composition including ?-Glu-Nva (L-?-glutamyl-L-norvaline), and a complex kokumi-imparting composition including the foregoing substance and another substance having a CaSR agonist activity, in combination.Type: ApplicationFiled: June 21, 2012Publication date: November 1, 2012Inventors: Takashi Miyaki, Naohiro Miyamura, Megumi Kaneko, Yusuke Amino, Reiko Yasuda, Yuzuru Eto, Takaho Tajima
-
Publication number: 20120034364Abstract: The inventors of this invention have conducted the search for a variety of compounds which may possess a desired CaSR agonist activity to thus find out a substance capable of imparting a kokumi, which shows a more excellent kokumi-imparting effect, in particular, a kokumi-imparting effect of the initial taste-imparting type one, which is excellent in the stability and which can easily be produced at a low cost and the present invention thus provide a kokumi-imparting agent consisting of such a substance as well as a complex kokumi-imparting agent comprising the substance and other substances possessing the CaSR agonist activities in combination. More particularly, the present invention herein provides a kokumi-imparting agent consisting of ?-Glu-Abu (L-?-glutamyl-L-2-amino-butyric acid) and a complex kokumi-imparting agent comprising the foregoing substance and another substance having a CaSR agonist activity, in combination.Type: ApplicationFiled: September 30, 2011Publication date: February 9, 2012Inventors: FUMIE FUTAKI, Reiko Yasuda, Seiichi Sato, Takashi Miyaki, Naohiro Miyamura, Yuzuru Eto
-
Publication number: 20110251418Abstract: By searching various kinds of compounds having CaSR agonistic activity, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise the compound. More specifically, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise a glutamic acid derivative having CaSR agonistic activity or pharmaceutically acceptable salts thereof.Type: ApplicationFiled: April 4, 2011Publication date: October 13, 2011Applicant: AJINOMOTO CO., INC.Inventors: Masayuki Sugiki, Toru Okamatsu, Sayaka Asari, Yayoi Kawato, Toshihiro Hatanaka, Tetsuo Yano, Yukie Seki, Naohiro Miyamura, Hiroaki Nagasaki, Yuzuru Eto, Reiko Yasuda